U.S. drugmaker Eli Lilly said on Monday it will offer the higher-dose versions of its popular weight-loss drug Zepbound on ...

Pennsylvania Governor Josh Shapiro's office has said it is looking to change eligibility for weight loss drugs as part of its ...

Eli Lilly's drug, called eloralintide, helped some patients lose more than 11% of their body weight in three months.

An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could eventually be an alternative or add-on to popular GLP-1 medications.

Former FDA chief Dr. David Kessler says the new weight-loss drugs are a powerful tool to fight obesity. But they come with ...

suburbs to South Jersey and Delaware, what would you like WHYY News to cover? Let us know! Ever since blockbuster weight-loss drugs like Wegovy and Zepbound went mainstream, calls to local poison ...

Dr. Shervin Naderi and his team integrate facial rejuvenation with weight loss care to manage the structural facial changes ...

With the addition of 12.5 mg and 15 mg vials, all approved doses of Zepbound will be available in single-dose vials for $499 /month or less, regardless of insurance ...

Temple University physician Rohit Soans worries that patients using weight-loss medications may be considering risky options to keep taking these popular drugs. As new restrictions on popular GLP-1 ...

What happens when you stop taking weight loss drugs like Mounjaro and Ozempic? - Studies find that many people return to ...

In 2025, it feels like prescription weight-loss drugs have gone from mainstream to mania—we all know someone (or many someones) using them, and ads for different versions have taken over our ...

Long-term use of weight loss drugs can lead to sustained weight decreases and improvements in overall metabolic health but must be paired with healthy eating and exercise. There are a few factors ...